FLASCO

e-Learning

Home » Resources » e-Learning

FLASCO Administrator Network Patient Support Resources Webinar

Posted January 12, 2017

  On January 12, 2017, the FLASCO Administrator Network hosted its first webinar. The topic was Patient Support Resources, and it featured experts from community oncology  and hospital settings, who shared their tips, helpful hints, and tools of the trade regarding assistance programs and resources available for cancer patients. Congratulations to Maggie Wiegandt, MBA and Gail...

teva oncology

INTevaGENCE: The Expert Forum for Advanced Oncology Care

Posted September 30, 2016

FLASCO is pleased to make you aware of a new offering from Teva Oncology; INTevaGENCE: The Expert Forum for Advancing Oncology Care. INTevaGENCE offers an online expert forum where seasoned presenters bring information, tools, instruction, and expert perspectives. The topics covered in INTevaGENCE are Oncology Nurse Navigation, Continuous Improvement of Quality and Patient Satisfaction and...

Genentech’s TECENTRIQ Upcoming Webinars

Posted September 15, 2016

On behalf of Genentech, you are invited to attend one of three webcasts across two days that span lunch times across 3 time zones: Introducing TECENTRIQ: The First and Only FDA-Approved Anti-PDL1 Immunotherapy for Previously Treated Locally Advanced Metastatic Urothelial Carcinoma September 28, 2016 Fairooz Kabbinavar, MD – UCLA, Los Angeles, CA 3:00pm ET, 2:00pm...

ASCO Annual Meeting Collective Wisdom

Posted September 12, 2016

Novartis Oncology is pleased to invite you to virtually attend sessions from the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting. To access the virtual platform please register at www.asco2016.com/FLASCO to begin viewing the recorded video sessions in the single track of your choice and learn about the practice-changing advances in oncology presented at...

myriad genetics

Myriad myPlan Lung Cancer

Posted July 28, 2016

Myriad’s myPlan® Lung Cancer is a new gene expression signature based on 31 cell cycle progression (CCP) genes —the genes that regulate cell division. myPlan Lung Cancer measures the expression levels of specific genes in combination with pathological stage to predict the 5-year risk of lung cancer death in patients with surgically resected early-stage NSCLC. ...

alexion

Patient Case #2

Posted June 9, 2016

Click here to read a case about a 43-year- old female who was admitted to the hospital for headaches and nausea and who died from a myocardial infarction. Review the patient’s symptoms, course of treatment, and family history that led her healthcare team to diagnose her, post-mortem, with an ultra-rare disease.   *These educational programs...

alexion

Patient Case #1

Posted June 9, 2016

Click here to read a case about a 51-year- old female with a medical history of recurrent venous thromboembolism (VTE). Review the patient’s medical history and lab results that led her healthcare team to diagnose her with an ultra-rare disease.   *These educational programs are offered through the generous support of Alexion Pharmaceuticals, Inc. Questions?...

alexion

How to make a differential diagnosis of thrombotic microangiopathies (TMAs)

Posted March 31, 2016

Dr. Jeffrey Laurence, MD – Understanding Atypical Hemolytic Uremic Syndrome
Professor, Weill Cornell Medical College, New York, NY
Understanding Atypical Hemolytic Uremic Syndrome (aHUS)
“…outcome is highly unfavorable in aHUS treated with PE. Up to 50% of patients progress to end-stage renal failure within a year, and 25% die during the acute phase.” -Laurence, Clinical Advances in Hem/Oncology. 2012

XTANDI

Posted August 3, 2015

Astellas Pharmaceuticals Start XTANDI at disease progression to metastatic CRPC for your patients on GnRH therapy*1. Click here to create your signature program.  

Who’s Online

There are no users currently online